Canada’s three research funding agencies have launched the Tri-agency Interdisciplinary Peer Review Committee; Alberta creates a platform to boost clinical trials; Ontario Tech University is designated a collaboration centre by the UN International Atomic Energy Agency, and more.
Organization: Genesys Capital
Fusion Pharmaceuticals Inc, a spin out of the Centre for Probe Development and Commercialization (CPDC), has secured US$25 million in series ‘A’ financing to support and accelerate development of new next-generation therapeutics that precisely target cancer cells.
Montreal-based Allostera Pharma Inc has raised $17 million in series ‘A’ financing to develop a new class of drugs based on the firm’s proprietary Module X platform technology. So-called allosteramers use modified peptides with highly specific targets that can be developed rapidly and can be taken orally, which may make them more widely accepted than…